Karyopharm to participate at the 2022 rbc capital markets global healthcare conference

Newton, mass. , may 10, 2022 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the company's senior management team will participate in a fireside chat at the 2022 rbc capital markets global healthcare conference on tuesday, may 17, 2022 at 4:35 p.m.
KPTI Ratings Summary
KPTI Quant Ranking